Stock Comparison
LLY vs MRK
Eli Lilly and Company and Merck & Company Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$1.08T
$317.77B
P/E (TTM)
42.9
36.2
Forward P/E
31.1
25.5
Price/Sales
14.9
4.8
Price/Book
32.2
6.9
EV/EBITDA
28.8
18.6
Dividend Yield
0.55%
2.61%
Profitability
Net Margin
35.00%
13.60%
Operating Margin
49.40%
38.60%
Return on Equity
107.50%
18.90%
Return on Assets
20.70%
12.60%
Growth (YoY)
Revenue Growth
55.50%
4.90%
Earnings Growth
169.90%
-19.30%
Price & Risk
Beta
0.5
0.2
52-Week High
$1,215.76
$128.78
52-Week Low
$619.40
$74.18
Analyst Target
$1,222.62
$130.39
Compare LLY and MRK your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.